Veracyte | VCYT - Current Assets


Veracyte reported $488.38M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agenus USD 133.95M 120.61M Sep/2025
Agilent USD 4.62B 21M Dec/2025
Anika Therapeutics USD 101.59M 2.27M Sep/2025
Arrowhead Research USD 1.17B 223.75M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Exact Sciences USD 1.56B 34.88M Dec/2025
Heron Therapeutics USD 238.07M 8.67M Dec/2025
Illumina USD 3.29B 493M Dec/2025
Intrexon USD 23.72M 45.04M Jun/2024
Karyopharm Therapeutics USD 89.75M 8.12M Sep/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Ligand Pharmaceuticals USD 832.27M 78.35M Dec/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Rigel Pharmaceuticals USD 214.93M 39.53M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Siemens EUR 67.91B 3.2B Dec/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Veracyte USD 488.38M 39.15M Dec/2025
Waters USD 1.99B 69.86M Dec/2025